Clinical Trials Browser

Phase 2 × Has results × Metastatic Castration-resistant Prostate Cancer × Clear all

NCT04158245 2025-09-22

18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies

Phase 2 Completed

9 enrolled 14 charts

Metastatic Castration-resistant Prostate Cancer

NCT03770455 2024-07-09

Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC

Phase 2 Terminated

8 enrolled 7 charts

Metastatic Castration-resistant Prostate Cancer

NCT01942837 2022-10-24

Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

Phase 2 Completed

67 enrolled 17 charts

Metastatic Castration-resistant Prostate Cancer